Advanced Medical Isotope Corp. (ADMD) Moves to Acquire Key Russian Medical Isotope Company’s Assets, Engages Global TechInnovations and Plans for Further Acquisitions
Advanced Medical Isotope has built a small empire around the development and production of critical medical isotopes used in advanced diagnostic testing, as well as non-surgical therapies, and recently announced a move to capture additional market territory, engaging investment and professional services firm Global TechInnovations to assist in the acquisition of a key Russian isotope producer.
This move to acquire the Russian company’s assets, which include an existing global sales footprint and proprietary contracts, in addition to copious extant work by strategic science/production partners and the essential separation process technologies, is but the first step into the region for ADMD. Global TechInnovations will spearhead ADMD’s future acquisitive efforts in Russia/FSU states (Former Soviet Union) as well, acting as a tactical advisor and service support envelope for the various meetings and negotiations, as well as post-acquisition support.
Chairman and CEO of ADMD, James C. Katzaroff, spoke of the initial approach by the Company in going to bedrock institution and non-profit corporate membership association, the USIC (U.S. Industry Coalition), on the basis of its well-known reputation for being dedicated to its members and for the USIC’s powerful global influence. Katzaroff indicated that plans were underway to go further after the acquisition, expanding ADMD’s technological capabilities, as well as the Company’s global reach. Confidence in a positive conclusion to this acquisition, thanks in large part to the USIC and Global TechInnovations, has primed ADMD for expansion in Russia and Katzaroff posited enhanced competitive position and organizational improvements as other natural results.
Managing Director of Global TechInnovations, Artour Baganov, spoke of the worked conducted between the USIC and non-profit international science/technology collaboration facilitator CRDF Global, which has extensive work in the international scientific research area, an often extremely complex and challenging environment. Baganov even hailed Katzaroff himself as an “innovator who is adept at identifying as well as leveraging advantageous international nuclear medical technology opportunities,” defining a clear horizon for ADMD’s potential.
These developments are perfectly in line with ADMD’s strategy of bringing the medical community the essential isotopes that have been, up until recently, either prohibitively expensive or otherwise infeasible and which are so important to emerging therapies and the diagnostics involved in developing cures for disease.
For more information on the acquisition, engagement of Global TechInnovations, or on the Company itself, please visit the Advanced Medical Isotope Corp. website located at www.IsotopeWorld.com
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment